13F HOLDINGS REPORT
Omega Fund Management, LLC
Quarter ended Q3 2023 · Filed August 14, 2023 · Accession 0000950123-23-007696
Total Value
$178.5M
Positions
12
Other Managers
0
Confidential Omitted
No
Holdings (12)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Replimune Group | REPL | 3,001,319 | $69.7M | 39.05% |
| 2 | Nuvation Bio | NUVB | 15,072,340 | $27.1M | 15.20% |
| 3 | Alpine Immune Sciences | 02083G100 | 2,029,580 | $20.9M | 11.69% |
| 4 | Morphic Holding | 61775R105 | 309,846 | $17.8M | 9.95% |
| 5 | Ikena Oncology | 45175G108 | 2,249,123 | $14.8M | 8.27% |
| 6 | Theseus Pharmaceuticals | 88369M101 | 711,479 | $6.6M | 3.72% |
| 7 | Kronos Bio | 50107A104 | 3,818,283 | $6.6M | 3.68% |
| 8 | Sana Biotechnology, Inc. | SANA | 843,750 | $5.0M | 2.82% |
| 9 | Spruce Biosciences | SPRB | 2,161,022 | $4.6M | 2.60% |
| 10 | Immunic Inc | IMUX | 1,788,160 | $4.5M | 2.51% |
| 11 | Syros Pharmaceuticals | 87184Q206 | 251,270 | $791,500 | 0.44% |
| 12 | Senti Biosciences, Inc. | SNTI | 195,792 | $122,762 | 0.07% |